Arca
Skip to content
Tools
Tools

Nicotinamide adenine dinucleotide (NAD+): 100mg/mL

Recall D-0478-2025, part of FDA recall event 96742. See Thrive Health and Wellness (Thrive Health Solutions)'s company page.

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) started this Class II drug recall on May 21, 2025 (voluntary: firm initiated); FDA lists it as ongoing.

  • Classification: Class II
  • Started: May 21, 2025
  • Status: Ongoing
  • Products in this event: 14

Why It Was Recalled

Class II

Lack of Assurance of Sterility

Record

Product
Nicotinamide adenine dinucleotide (NAD+): 100mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112
Quantity
16 syringes
Lots and codes
Lot #: O-O8A01-25, Exp 3/7/2025
Distribution
USA Nationwide
Recalling firm
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado), Englewood, CO, United States
How the firm notified
E-Mail
FDA classified
Jun 20, 2025

Other Products in This Recall

Recall event 96742

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.